Published in Oncol Lett on November 07, 2013
Radioprotective effects of valproic acid, a histone deacetylase inhibitor, in the rat brain. Biomed Rep (2014) 0.79
Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis. PLoS One (2015) 0.78
Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma. Oncol Lett (2015) 0.76
Valproic acid promotes radiosensitization in meningioma stem-like cells. Oncotarget (2015) 0.76
Anti-inflammatory and Anti-apoptotic Effect of Valproic Acid and Doxycycline Independent from MMP Inhibition in Early Radiation Damage. Balkan Med J (2016) 0.75
MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma. Oncol Lett (2015) 0.75
Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression. Oncotarget (2017) 0.75
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem (1998) 28.13
Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol (1997) 9.18
Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer (2001) 9.12
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov (2002) 6.97
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem (2001) 6.85
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J (2001) 6.85
Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem (2009) 3.88
Histone deacetylases. Curr Opin Pharmacol (2003) 2.58
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res (2005) 2.09
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther (2006) 1.84
Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol (2007) 1.77
Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res (2004) 1.73
BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, BCL-2, and caspases. J Neurosci (1999) 1.59
Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer. Cancer Res (2006) 1.58
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int J Cancer (2005) 1.56
Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms. J Neurooncol (2012) 1.52
Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med (2011) 1.42
Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene (1996) 1.26
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Radiat Res (2004) 1.26
"...those left behind." Biology and oncology of invasive glioma cells. Neoplasia (1999) 1.24
HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. Oncogene (2009) 1.22
Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair. Br J Cancer (2013) 1.22
Histone deacetylase inhibitors and cancer: from cell biology to the clinic. Eur J Cell Biol (2005) 1.19
Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation. Clin Cancer Res (2004) 1.17
Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts. Mol Cancer Ther (2009) 1.09
Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic. J Cell Mol Med (2011) 1.07
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. Int J Radiat Oncol Biol Phys (2004) 1.07
HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells. Cancer Biother Radiopharm (2009) 1.06
Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status. Int J Radiat Oncol Biol Phys (2009) 1.05
Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Cancer Lett (2005) 1.02
Valproate: a simple chemical with so much to offer. J Clin Pharm Ther (2005) 0.98
The role and clinical significance of DNA damage response and repair pathways in primary brain tumors. Cell Biosci (2013) 0.89
Hydrogen peroxide is a mediator of indole-3-acetic acid/horseradish peroxidase-induced apoptosis. FEBS Lett (2006) 0.87
Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy. Eur J Radiol (2008) 0.85
Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells. J Interferon Cytokine Res (1998) 0.83
Caspase-dependent cell death mediates potent cytotoxicity of sulfide derivatives of 9-anilinoacridine. Anticancer Drugs (2008) 0.83
Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation. J Neurosurg (2008) 0.81
Radiosensitivity enhancement by arsenic trioxide in conjunction with hyperthermia in the EC-1 esophageal carcinoma cell line. Asian Pac J Cancer Prev (2012) 0.80
Typical cell signaling response to ionizing radiation: DNA damage and extranuclear damage. Chin J Cancer Res (2012) 0.80
Variable Bax antigenicity is linked to keratinocyte position within epidermal strata and UV-induced apoptosis. Exp Dermatol (2007) 0.79
Toxicity, biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues and tumors in rodents: comparison with prior results with phosphorothioates. Radiother Oncol (1995) 0.79
Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression. Neuroscience (2008) 0.77
Tirilazad does not protect rat brain from brachytherapy-induced injury. Surg Neurol (1996) 0.77
Radioprotective effects of valproic acid, a histone deacetylase inhibitor, in the rat brain. Biomed Rep (2014) 0.79